News

17 news articles are available

20/06/2017

Lessons learned from the Q1 2017 earnings season

As the earnings season comes to a close, the time has come to report back on what we have found.

20/06/2017

Biosimilars – Now a reality even for complex biologics

Within the next five years, Biosimilars should take an increasingly important role as a powerful force driving down the cost of healthcare in the US and elsewhere or enabling more patients to gain access to some of the most complex biologics: eight therapies among the world’s Top 10 could face biosimilar competition, mostly in the field of inflammation.

20/06/2017

Our Convictions

This section develops our central scenario and our main convictions. It highlights the main orientations of our asset allocation and presents the strategies that characterize the structure of our portfolios:bond portfolios, equity portfolios and diversified portfolios.